Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 22. November 2024
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1759  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 35166  
   
Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study.
Front Immunol
Xu Q, Yi D, Jia C, Kong F, Jia Y.
PMID: 39575245 [PubMed - indexed for MEDLINE]


Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies.
Front Epidemiol
Bouajila N, Domenighetti C, Aubin HJ, Naassila M.
PMID: 39574800 [PubMed]


Comparison of machine learning methods for Predicting 3-Year survival in elderly esophageal squamous cancer patients based on oxidative stress.
BMC Cancer
Xie JB, Huang SJ, Yang TB, Wang W, Chen BY, Guo L.
PMID: 39574068 [PubMed - indexed for MEDLINE]


Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials.
BMC Gastroenterol
Lei X, Huo W, Xu T, Xu J, Liu M, Liu C, Gu Z.
PMID: 39573989 [PubMed - indexed for MEDLINE]


Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer.
Sci Rep
Lin Y, Wang SF, Liang HW, Liu Y, Huang W, Pan XB.
PMID: 39572671 [PubMed - indexed for MEDLINE]


Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso.
Int J Clin Pharm
Sugaya S, Uchida M, Suzuki T, Kawakami E, Ishii I.
PMID: 39570570 [PubMed - as supplied by publisher]


The prognostic value of pretreatment [(18)F]FDG PET/CT parameters in esophageal cancer: a meta-analysis.
Eur Radiol
Huang M, Wang W, Wang R, Tian R.
PMID: 39570366 [PubMed - as supplied by publisher]


ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS.
Arq Bras Cir Dig
Gallon E, Szachnowicz S, Duarte AF, Tustumi F, Sallum RAA, Herman P, Ribeiro Junior U.
PMID: 39570180 [PubMed - indexed for MEDLINE]


Risk of Cancer Diagnosis in Patients With Eosinophilic Esophagitis Using a Nationwide Swedish Population Cohort.
United European Gastroenterol J
Uchida AM, Schuman SS, Pyne A, Peterson K, Carlson M, Garber JJ, Roelstraete B, Ludvigsson JF.
PMID: 39565026 [PubMed - as supplied by publisher]


Esophageal melanosis: Two case reports and review of literature.
World J Gastroenterol
Kazacheuskaya L, Arora K.
PMID: 39563752 [PubMed - indexed for MEDLINE]


Helicobacter pylori, esophageal precancerous lesions, and proton pump inhibitor overuse.
World J Gastroenterol
Zhang F, Zhang H, Liu YM, Tang FS.
PMID: 39563751 [PubMed - indexed for MEDLINE]


Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.
Ther Adv Med Oncol
Lin Y, Shen W, Ye J, Luo H, Zhang X, Xu Y, Lin Q, Liu W, Zhang Y, Xu Y, Jiang W, Zhao L, Liu A, Wu L, Ge H, Xie C, Zhao K, Chen J, Wang L, Liu Q.
PMID: 39563718 [PubMed]


Optimizing neoadjuvant radiotherapy for locally advanced esophageal squamous cell carcinoma: a comprehensive review on the role of concomitant or sequential immune checkpoint inhibitors.
Esophagus
Ghalehtaki R, Amini A, Abyaneh R.
PMID: 39562407 [PubMed - as supplied by publisher]


Survival benefit of adjuvant therapy following neoadjuvant therapy in patients with resected esophageal cancer: A retrospective cohort study.
PLoS One
Jia W, Li C, Liu C, Hu R.
PMID: 39561158 [PubMed - indexed for MEDLINE]


Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment.
Eur Rev Med Pharmacol Sci
Teke Z, Bisgin A, Oruc Rencuzogullari C, Eren Erdogan K, Parsak CK, Kalkanli Tas S.
PMID: 39560927 [PubMed - indexed for MEDLINE]


Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study.
Discov Oncol
Liu J, Tang R, Zheng J, Luo K.
PMID: 39560863 [PubMed]


An Institutional Experience of Core Needle Biopsy with Cooperative Implementation by Pathologists and Head and Neck Oncologists in Salivary Gland Carcinoma.
Head Neck Pathol
Kobayashi K, Yoshimoto S, Omura G, Matsumoto Y, Sakai A, Eguchi K, Sakai T, Honma Y, Matsumoto F, Kawazu M, Saito Y, Ryo E, Yoshida A, Yatabe Y, Mori T.
PMID: 39560855 [PubMed - indexed for MEDLINE]


The diagnostic value of endoscopic ultrasound for esophageal subepithelial lesions: A review.
Medicine (Baltimore)
Li W, Shao M, Hu S, Xie S, He B.
PMID: 39560558 [PubMed - indexed for MEDLINE]


Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway.
Biomol Biomed
Yin H, Zheng Y, Yuan Z, Han X, Jiang D, Li D, Song F.
PMID: 39558814 [PubMed - as supplied by publisher]


A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case-control study.
Sci Prog
Ren J, Wang K, Zhao J, Xu C, Liu C, Wang Y, Wang G.
PMID: 39558764 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 35166    Seite 1 von 1759  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1